While no resource is perfect, it is worthwhile to familiarize yourself with some contemporary methodology and predictive tools to help determine life expectancy in localized prostate cancer patients.

Casdatifan showed a 35% confirmed ORR in the 100 mg cohort, with median PFS not reached, indicating promising efficacy. The pooled analysis revealed a 31% ORR and a median PFS of 12.2 months, ...

EG110A targets type C sensory neurons to manage neurogenic detrusor overactivity-related incontinence, preserving other bladder controls. Fast track designation by the FDA allows EG110A to benefit ...

CAN-2409 plus valacyclovir significantly improved disease-free survival compared with placebo plus valacyclovir. Phase 3 data from the PrTK03 trial (NCT01436968) were recently presented at the ...

"The world of laser vaginal rejuvenation is fast paced, with new companies adding a laser platform nearly each month," write Jessica DeLong, MD, and Jennifer Miles-Thomas, MD.

"Liquid biopsy analysis provides a noninvasive and facile tool for early detection, diagnosis, and recurrence surveillance of urological cancer," writes Jim Lu, MD, PhD.

A. Lenore Ackerman, MD, PhD, outlines the rationale for a guideline recommendation suggesting that D-mannose alone may not be effective for UTI prophylaxis. Ackerman is a urogynecologist at the ...

The Expert APProach: Conversations in Uro-Oncology, hosted by Joy Maulik, CRNP, is the latest multimedia program from Urology Times. In this debut episode of The Expert APProach: Conversations in ...

Flibanserin received FDA priority review for expanded use in postmenopausal women with hypoactive sexual desire disorder, building on its 2015 approval for premenopausal women. Gepotidacin was ...

FDA approved gemcitabine intravesical system for BCG-unresponsive NMIBC, showing an 82% complete response rate in the SunRISe-1 trial. CAN-2409 plus valacyclovir significantly improved disease-free ...

Melvin L.K. Chua, FRCR, PhD, FASCO, highlights data validating the performance of the ArteraAI Prostate test in an Asian cohort of patients with prostate cancer. Data presented at the American Society ...

Giri is a professor of internal medicine in medical oncology, the director of the Cancer Genetics and Prevention Program at Yale Cancer Center Smillow Cancer Hospital, and the director of the Early ...